Abstract:Abiotic D-proteins that selectively bind to natural L-proteins have gained significant biotechnological interest. However, the underlying structural principles governing such heterochiral protein-protein interactions remain largely unknown. In this study, we present the de novo design of D-proteins consisting of 50-65 residues, aiming to target specific surface regions of L-proteins or L-peptides. Our designer D-protein binders exhibit nanomolar affinity toward an artificial L-peptide, as well as two naturally occurring proteins of therapeutic significance: the D5 domain of human tropomyosin receptor kinase A (TrkA) and human interleukin-6 (IL-6). Notably, these D-protein binders demonstrate high enantiomeric specificity and target specificity. In cell-based experiments, designer D-protein binders effectively inhibited the downstream signaling of TrkA and IL-6 with high potency. Moreover, these binders exhibited remarkable thermal stability and resistance to protease degradation. Crystal structure of the designed heterochiral D-protein-L-peptide complex, obtained at a resolution of 2.0 Å, closely resembled the design model, indicating that the computational method employed is highly accurate. Furthermore, the crystal structure provides valuable information regarding the interactions between helical L-peptides and D-proteins, particularly elucidating a novel mode of heterochiral helix-helix interactions. Leveraging the design of D-proteins specifically targeting L-peptides or L-proteins opens up avenues for systematic exploration of the mirror-image protein universe, paving the way for a diverse range of applications.

Mirror-image Protein and Peptide Drug Discovery Through Mirror-Image Phage Display

Mirror-image ligand discovery enabled by single-shot fast-flow synthesis of D-proteins

D‐Peptide‐Based Drug Discovery Aided by Chemical Protein Synthesis

Mirror-image Isomers Screening: Overcoming the Enzyme Barriers for the Development of Peptide and Oligonucleotide Therapeutics

Studies on Mirror-Image Proteins

Virus-Derived Peptides for Clinical Applications

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

Mirror-image trypsin digestion and sequencing of D-proteins

An Enzyme‐Cleavable Solubilizing‐Tag Facilitates the Chemical Synthesis of Mirror‐Image Proteins

Backbone-Installed Split Intein-Assisted Ligation for the Chemical Synthesis of Mirror-Image Proteins

Chemical Protein Synthesis-Assisted High-Throughput Screening Strategies for D-Peptides in Drug Discovery

Is the Mirror Image a True Reflection? Intrinsic Membrane Chirality Modulates Peptide Binding

Generating Recombinant Antibodies to Membrane Proteins through Phage Display

Mirror proteases of Ac-Trypsin and Ac-LysargiNase precisely improve novel event identifications in Mycolicibacterium smegmatis MC2 155 by proteogenomic analysis

Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing D-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14

De Novo Screening and Mirror Image Isomerization of Linear Peptides Targeting Α7 Nicotinic Acetylcholine Receptor.

Recent advances in chemical protein synthesis: method developments and biological applications

Engineering a Low-Immunogenic Mirror-Image VHH against Vascular Endothelial Growth Factor

Diversification of Phage-Displayed Peptide Libraries with Noncanonical Amino Acid Mutagenesis and Chemical Modification

Accurate de novo design of heterochiral protein-protein interactions

Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update